KFAS
RMD icon

Keating Financial Advisory Services’s ResMed RMD Stock Holding History

Keating Financial Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
538
-91
-14% -$18.9K 0.01% 477
2026
Q1 		$141K Sell
629
-90
-13% -$22.4K 0.02% 397
2025
Q4 		$173K Buy
+719
New +$184K 0.02% 399

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Keating Financial Advisory Services's RMD Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $18.9K and leaving 538 shares worth $105K. The position accounts for 0.01% of the portfolio, ranked #477.

Keating Financial Advisory Services first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $173K in Q4 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Keating Financial Advisory Services held 538 shares of ResMed worth $105K as of Q2 2026.
  • Keating Financial Advisory Services sold 91 ResMed shares in Q2 2026, an estimated $18.9K.
  • ResMed made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #477 holding.
  • Keating Financial Advisory Services first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's ResMed position peaked at $173K in Q4 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.